Day: June 6, 2021

iSIGN Media Selected as Exclusive Technology Platform for Proof-of-Concept Installation for Contact Tracing in Airports and Municipally Managed Public Spaces

iSIGN Media Selected as Exclusive Technology Platform for Proof-of-Concept Installation for Contact Tracing in Airports and Municipally Managed Public Spaces

Written by Customer Service on . Posted in Public Companies.

TORONTO, June 06, 2021 (GLOBE NEWSWIRE) — iSIGN Media Solutions Inc. (“iSIGN” or “Company”) (TSX-V: ISD) (OTC: ISDSF), a leading provider of interactive mobile proximity marketing and public security alert solutions announced that the Company has been selected by SIMBL Business Enablement Inc. as the Exclusive Technology Platform in an on-going proof-of-concept (“POC”) contract between SIMBL Business Enablement Inc. and Innovation Solutions Canada (“ISC”), with the paid POC deployment currently underway at Prince George Airport in British Columbia. This POC program, called Passive Historical Aggregate Contact Tracing (“PHACT”) has been approved and vetted by the ISC. PHACT has been designed from the outset to address the shortcomings of traditional app-based systems.   The platform utilizes iSIGN’s proprietary technology to overcome...

Continue reading

Iovance Biotherapeutics Announces 33-Month Follow Up Data for Lifileucel in Advanced Melanoma at ASCO 2021 Annual Meeting

Iovance Biotherapeutics Announces 33-Month Follow Up Data for Lifileucel in Advanced Melanoma at ASCO 2021 Annual Meeting

Written by Customer Service on . Posted in Public Companies.

Median Duration of Response (DOR) Not Reached at 33.1 Months of Median Study Follow Up in Cohort 2 in C-144-01 Study Early Intervention with Lifileucel Following Progression on Anti-PD-1 Therapy May Maximize Benefit ASCO Update Conference Call and Webcast at 12 p.m. ET Today SAN CARLOS, Calif., June 06, 2021 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced updated clinical data for lifileucel from Cohort 2 in the C-144-01 clinical study in patients with advanced melanoma. The data were presented in an oral presentation at the ASCO 2021 Annual Meeting. Omid Hamid, M.D., Chief of Research/Immuno-Oncology, The Angeles Clinic & Research Institute, stated, “Anti-PD-1 therapy is a mainstay class of treatment offering...

Continue reading

Novartis announces iptacopan met Phase II study primary endpoint in rare kidney disease IgA nephropathy (IgAN)

Novartis announces iptacopan met Phase II study primary endpoint in rare kidney disease IgA nephropathy (IgAN)

Written by Customer Service on . Posted in Public Companies.

Phase II primary endpoint results for investigational iptacopan in IgAN demonstrated effective and clinically meaningful reduction of proteinuria1 – a key risk predictor in kidney disease progression2 Iptacopan also showed a trend toward stabilization of kidney function1; Phase III clinical trial APPLAUSE is underway There are no currently approved treatments for IgAN – a rare and often progressive kidney disease that mainly affects young adults and can progress to kidney failure3-7 Iptacopan is in development for several complement-driven renal diseases (CDRDs), including IgAN and C3 glomerulopathy (C3G), and the blood disorder paroxysmal nocturnal hemoglobinuria (PNH), targeting a key driver of these diseases Basel, June 06, 2021 — Novartis today announced Phase II primary endpoint data showing investigational iptacopan (LNP023)...

Continue reading

Enjoy Low and Competitive lap Loan Interest Rate

Written by Customer Service on . Posted in Public Companies.

If you are looking for funds to take your business to new heights, you do not need to worry about the tedious eligibility criteria or heavy documentation. You can apply for a loan against property and enjoy high loan amount at low interest rate. Hero FinCorp is a reliable lender in the country with a presence across every corner of India. They offer low lap loan interest rate and will ensure that the loan serves your purpose. Hero FinCorp has a stronghold on the industry and is considered as one of the best today. You can use your commercial or residential property for the purpose of the loan. It can be in use, rented or leased. The loan application procedure is simple and hassle free. Hero FinCorp strives to help individuals turn their dreams into a reality and no matter the size or type of business you own, you are eligible for the loan....

Continue reading

Toga Limited’s Social Media App Yippi Launches “Yipps Wanted” Program to Provide a Seamless Business Solutions for Merchants

Toga Limited’s Social Media App Yippi Launches “Yipps Wanted” Program to Provide a Seamless Business Solutions for Merchants

Written by Customer Service on . Posted in Public Companies.

PETALING JAYA, Malaysia, June 05, 2021 (GLOBE NEWSWIRE) — Toga Limited’s (OTC:TOGL) social media mobile app, Yippi, launches “Yipps Wanted” program, an end-to-end e-commerce platform solution, aimed at assisting small medium businesses (SMBs) and enterprises (SMEs) in Malaysia to increase the number of customers and drive traffic to their physical and or online stores. The “Yipps Wanted” program is available in a mini program on the Yippi platform, and a merchant mobile application. As a mini program, “Yipps Wanted” offers customers and merchants chances to win prizes when they spend Yipps – the virtual reward points that can be redeemed in transactions conducted through the Yippi app. Merchants can also offer instant rewards to walk-in customers who spend in their stores simply by scanning their Yippi QR code via the mini program....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.